Molecular approaches to developmental malformations using analogous forms of valproic acid

Congenital Anomalies

Volumn 46, Issue 2, 2006, Pages 68-75

  Okada, Akinobu ^a,b   Fujiwara, Michio ^a  

^a Drug Safety Research Laboratories   (Japan)

^b Astellas Pharma   (Japan)

Author keywords

Birth defect; Malformation; Neural tube; Skeleton; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; VALNOCTAMIDE; VALPROIC ACID; VALPROIC ACID DERIVATIVE; VALPROMIDE;

ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; BIRTH DEFECT; CONGENITAL MALFORMATION; DNA MICROARRAY; DRUG METABOLISM; DRUG STRUCTURE; EMBRYO DEVELOPMENT; EPILEPSY; GENE MUTATION; GENOME; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SKELETON; TERATOGENICITY;

ABNORMALITIES; ANIMALS; ANTICONVULSANTS; EMBRYO; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME; MICE; MICE, TRANSGENIC; MODELS, CHEMICAL; MUTATION; NEURAL CREST; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; TIME FACTORS; VALPROIC ACID;

EID: 33646716238     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/j.1741-4520.2006.00105.x     Document Type: Review

References (96)

1. Akasaka T, Kanno M, Balling R, Mieza MA, Taniguchi M, Koseki H 1996 A role of mel-18, a Polycomb group-related vertebrate gene, during the anteroposterior specification of the axial skeleton. Development 122 : 1513 1522.
2. Alkema MJ, van der Lugt NMT, Bobeldijk RC, Berns A, van Lohuizen M 1995 Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice. Nature 374 : 724 727.
3. Aulthouse AL, Hitt DC 1994 The teratogenic effects of valproic acid in human chondrogenesis in vitro. Teratology 49 : 208 217.
4. Barel S, Yagen B, Schurig V et al. 1997 Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and epileptic patients. Clin Pharmacol Ther 61 : 442 449.
5. Basu A, Wezeman FH 2000 Developmental toxicity of valproic acid during embryonic chick vertebral chondrogenesis. Spine 25 : 2158 2164.
6. Bel-Vialar S, Coré N, Terranova R, Goudot V, Boned A, Djabali M 2000 Altered retinoic acid sensitivity and temporal expression of Hox genes in Polycomb-M33-deficient mice. Dev Biol 224 : 238 249.
7. Bennett GD, Wlodarczyk B, Calvin JA, Craig JC, Finnell RH 2000 Valproic acid-induced alterations in growth and neurotrophic factor. Reprod Toxicol 14 : 1 11.
8. Bialer M 1991 Clinical Pharmacology of valpromide. Clin Pharmacokinet 20 : 114 122.
9. Bialer M 1999 Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs. J Control Release 62 : 187 192.
10. Bialer M, Haj-Yehia A, Barzaghi N, Pisani F, Perucca E 1990 Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects. Eur J Pharmacol 38 : 289 291.
11. Binkerd PE, Rowland JM, Nau H, Hendrickx AG 1988 Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam Appl Toxicol 11 : 485 493.
12. Blotnik S, Bergman F, Bialer M 1996 Disposition of valpromide, valproic acid and valnoctamide in the brain, liver, plasma, and urine of rats. Drug Metab Dispos 24 : 560 564.
13. Cheng HL, Mostoslavsky R, Saito S et al. 2003 Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1) - deficient mice. Proc Natl Acad Sci USA 100 : 10794 10799.
14. Coccia EM, Cicala C, Charlesworth A et al. 1992 Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. Mol Cell Biol 12 : 3514 3521.
15. Collins EC, Appert A, Ariza-McNaughton L, Pannell R, Yamada Y, Rabbitts TH 2002 Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with AF9 after chromosomal translocation in leukemia. Mol Cell Biol 22 : 7313 7324.
16. Collins MD, Walling KM, Resnick E, Scott Jr WJ 1991 The effect of administration time on malformations induced by three anticonvulsant agents in C57BL/6J mice with emphasis on forelimb ectrodactyly. Teratology 44 : 617 627.
17. Copp AJ, Brook FA, Roberts HJ 1988 A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryo developing spinal neural tube defects. Development 104 : 285 295.
18. Coré N, Bel S, Gaunt SJ et al. 1997 Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. Development 124 : 721 729.
19. Craig JC, Bennett GD, Miranda RC, Mackler SA, Finnell RH 2000 Ribonucleotide reductase subunit r1: A gene conferring sensitivity to valproic acid-induced neural tube defects in mice. Teratology 61 : 305 313.
20. Dansky LV, Finnell RH 1991 Parental epilepsy, anticonvulsant drugs, and reproductive outcome: Epidemiologic and experimental findings spanning three decades; 2: Human studies. Reprod Toxicol 5 : 301 335.
21. Del Sal G, Ruaro ME, Philipson L, Schneider C 1992 The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 70 : 595 607.
22. Docterman KE, Smith SM 2002 of meis and men: Lessons from a microarray study of teratogen action. Teratology 66 : 217 223.
23. Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y 1999 Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol 19 : 7237 7244.
24. Ehlers K, Stürje H, Merker HJ, Nau H 1992 Valproic aid-induced spina bifida: A mouse model. Teratology 45 : 145 154.
25. Faiella A, Wernig M, Consalez GG et al. 2000 A mouse model for valproate teratogenicity: Parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 9 : 227 236.
26. Finnell RH, Dansky LV 1991 Parental epilepsy, anticonvulsant drugs, and reproductive outcome: Epidemiologic and experimental findings spanning three decades; 1: Animal studies. Reprod Toxicol 5 : 281 299.
27. Finnell RH, Gould A, Spiegelstein O 2003 Pathobiology and genetics of neural tube defects. Epilepsia 44 Suppl. 3 14 23.
28. Finnell RH, Junker WM, Wadman LK, Cabrera RM 2002 Gene expression profiling within the developing neural tube. Neurochem Res 27 : 1165 1180.
29. Garcia-Villalba P, Jimenez-Lara AM, Castillo AI, Aranda A 1997 Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression. DNA Cell Biol 16 : 421 431.
30. Gasser SM, Cockell MM 2001 The molecular biology of the SIR proteins. Gene 279 : 1 16.
31. Golden JA, Chernoff GF 1993 Intermittent pattern of neural tube closure in two strains of mice. Teratology 47 : 73 80.
32. Göttlicher M, Minucci S, Zhu P et al. 2001 Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20 : 6969 6978.
33. Gould A 1997 Functions of mammalian Polycomb group and trithorax group related genes. Curr Opin Genet Dev 7 : 488 494.
34. Guarente L 2000 Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 14 : 1021 1026.
35. Haj-Yehia A, Bialer M 1988 Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs. J Pharm Sci 77 : 831 834.
36. Haj-Yehia A, Bialer M 1989 Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity. Pharm Res 8 : 683 689.
37. Harris MJ, Juriloff DM 1999 Mini-review: Toward understanding mechanisms of genetic neural tube defects in mice. Teratology 60 : 292 305.
38. Hendrickx AG, Nau H, Binkerd P et al. 1988 Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: An interspecies comparison. Teratology 38 : 329 345.
39. Imai S, Armstrong CM, Kaeberlein M, Guarente L 2000 Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 : 795 800.
40. Isoherranen N 2003 Pharmacokinetic-pharmacodynamic relationships of 2S,3S-valnocatmide and its stereoisomer 2R,3S-valnoctamide in animal model for epilepsy. Pharm Res 20 : 1293 1301.
41. Isoherranen N, White HS, Finnell RH et al. 2002 Anticonvulsant profile and teratogenicity of N-methyl-tetramethylcyclopropyl carboxamide: A new antiiepileptic drug. Epilepsia 43 : 115 126.
42. Isoherranen N, Yagen B, Bialer M 2003 New CNS-active drugs which are second-generation valproic acid: Can they lead to the development of a magic bullet? Curr Opin Neurol 16 : 203 211.
43. Jeong MR, Hashimoto R, Senatorov VV et al. 2003 Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: A role of histone deacetylase inhibition. FEBS Lett 542 : 74 78.
44. Kao J, Brown NA, Schmid B, Goulding EH, Fabro S 1981 Teratogenicity of valproic acid: In vivo and in vitro investigations. Teratogenesis Carcinog Mutagen 1 : 367 382.
45. Keen CL, Taubeneck MW, Daston GP, Rogers JM, Gershwin ME 1993 Primary and secondary zinc deficiency as factors underlying abnormal CNS development. Ann N Y Acad Sci 678 : 37 47.
46. Kennison JA 1993 Transcriptional activation of Drosophila homeotic genes from distant regulatory elements. Trends Genet 9 : 75 79.
47. Kessel M 1992 Respecification of vertebral identities by retinoic acid. Development 115 : 487 501.
48. Kessel M, Gruss P 1991 Homeotic transformation of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell 67 : 89 104.
49. Kultima K, Nyström AM, Scholz B, Gustafson AL, Dencker L, Stigson M 2004 Valproic acid teratogenicity: A toxicogenomics approach. Environ Health Perspect 112 : 1225 1235.
50. Langston AW, Gudas LJ 1992 Identification of a retinoic acid responsive enhancer 3′ of the murine homeobox gene Hox-1.6. Mech Dev 38 : 217 227.
51. Lindekens H, Smolders I, Khan GM, Bialer M, Ebinger G, Michotte Y 2000 In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model for focal epilepsy. Pharm Res 17 : 1408 1413.
52. van der Lugt NMT, Alkema M, Berns A, Deschamps J 1996 The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. Mech Dev 58 : 153 164.
53. del Mar Lorente M, Marcos-Gutiérrez C, Pérez C et al. 2000 Loss- and gain-of-function mutations show a Polycomb group function for Ring1A in mice. Development 127 : 5093 5100.
54. McBurney MW, Yang X, Jardine K et al. 2003 The mammalian SIR2α protein has a role in embryogenesis and gametogenesis. Mol Cell Biol 23 : 38 54.
55. Menegola E, Broccia ML, Nau H, Prati M, Ricolfi R, Giavini E 1996 Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratogenesis Carcinog Mutagen 16 : 97 108.
56. Menegola E, Broccia ML, Prati M, Giavini E 1998 Stage-dependent skeletal malformations induced by valproic acid in rat. Int J Dev Biol 42 : 99 102.
57. Menegola E, Di Renzo F, Broccia ML et al. 2005 Inhibition of histone deacetylase activity on specific embryonic tissues as s new mechanism for teratogenicity. Birth Defects Res Part B Dev Reprod Toxicol 74 : 392 398.
58. Moore M, Keane PE, Vernieres JC, Simiand J, Roncucci R 1984 Valproate: Recent findings and perspectives. Epilepsia 25 Suppl. 1 S5 S9.
59. Nau H, Hauck RS, Ehlers K 1991 Valproic acid-induced neural tube defects in mouse and human: Aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol Toxicol 69 : 310 321.
60. Nau H, Hendrickx AG 1987 Valproic acid teratogenesis. ISI Atlas Sci Pharmacol 1 : 52 56.
61. Nau H, Löscher W 1986 Pharmacologic evaluation of various metabolites and analogs of valproic acid: Teratogenic potencies in mice. Fundam Appl Toxicol 6 : 669 676.
62. Nau H, Scott WJ 1987 Teratogenicity of valproic acid and related substances in the mouse: Drug accumulation and pH in the embryo during organogenesis and structure-activity considerations. Arch Toxicol 11 : 128 139.
63. O'Carroll D, Erhardt S, Pagani M, Barton SC, Surani MA, Jenuwein T 2001 The Polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 21 : 4330 4336.
64. Okada A, Kurihara H, Aoki Y, Bialer M, Fujiwara M 2004a Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Birth Defects Res Part B Dev Reprod Toxicol 71 : 47 53.
65. Okada A, Aoki Y, Kushima K, Kurihara H, Bialer M, Fujiwara M 2004b Polycomb homologues are involved in teratogenicity of valproic acid in mice. Birth Defects Res Part A Clin Mol Teratol 70 : 870 879.
66. Okada A, Kushima K, Aoki Y, Bialer M, Fujiwara M 2005a Identification of early responsive genes correlated to valproic acid induced neural tube defects in mice. Birth Defects Res Part A Clin Mol Teratol 73 : 229 238.
67. Okada A, Shiomi T, Aoki Y, Fujiwara M 2005b Phenytoin stimulates chondrogenic differentiation in mouse clonal chondrogenic EC cells, ATDC5. J Txicol Sci 30 : 145 156.
68. Ong LL, Schardein JL, Petrere JA et al. 1983 Teratogenesis of calcium valproate in rats. Fundam Appl Toxicol 3 : 121 126.
69. Padmanabhan R, Ahmed I 1996 Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses. Reprod Toxicol 10 : 345 363.
70. Padmanabhan R, Hameed MS 1994 Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse. J Craniofac Genet Dev Biol 14 : 192 205.
71. Paro R 1990 Imprinting a determined state into the chromatin of Drosophila. Trends Genet 6 : 416 421.
72. Petrere JA, Anderson JA, Sakowski R, Fitzgerald JE, de la Iglesia FA 1986 Teratogenesis of calcium valproate in rabbits. Teratology 34 : 263 269.
73. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS 2001 Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276 : 36734 36741.
74. Pirotta V 1997 Chromatin-silencing mechanisms in Drosophila maintain patterns of gene expression. Trends Genet 13 : 314 318.
75. Popperl H, Featherstone MS 1993 Identification of a retinoic acid response element upstream of the murine Hox-4.2 gene. Mol Cell Biol 13 : 257 265.
76. Radatz M, Ehlers K, Yagen B, Bialer M, Nau H 1998 Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res 30 : 41 48.
77. Ross SA, McCaffery PJ, Drager UC, Luca LM 2000 Retinoids in embryonal development. Physiol Rev 80 : 1021 1054.
78. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T 1995 A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 10 : 175 179.
79. Schneider C, King RM, Philipson L 1988 Genes specifically expressed at growth arrest of mammalian cells. Cell 54 : 787 793.
80. Schumacher A, Faust C, Magnuson T 1996 Positional cloning of a global regulator of anterior-posterior patterning in mice. Nature 383 : 250 253.
81. Simeone A, Acampoca D, Negro V et al. 1991 Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells. Mech Dev 33 : 215 227.
82. Smith ML, Chen IT, Zhan Q et al. 1994 Interaction of the p53-regulated protein GADD45 with proliferating nuclear cell antigen. Science 266 : 1376 1379.
83. Sobol E, Bialer M, Yagen B 2004 Tetramethylcyclopropyl analogue of a leading antiepileptic drug, valproic acid. Synthesis and evaluation of anticonvulsant activity of its amide derivatives. J Med Chem 47 : 4316 4326.
84. Suzuki M, Mizutani-Koseki Y, Fujimura Y et al. 2002 Involvement of the Polycomb-group gene Ring1B in the specification of the anterior-posterior axis in mice. Development 129 : 4171 4183.
85. Takihara Y, Tomotsune D, Shirai M et al. 1997 Targeted disruption of the mouse homologue of the Drosophila polyhomeotic gene leads to altered anteroposterior patterning and neural crest defects. Development 124 : 3673 3682.
86. Tomotsune D, Shirai M, Takihara Y, Shimada K 2000 Regulation of Hoxb3 expression in the hindbrain and pharyngeal arches by rae28, a member of the mammalian Polyomb group of genes. Mech Dev 98 : 165 169.
87. Vacha SJ, Bennett GD, Mackler SA, Koebbe MJ, Finnell RH 1997 Identification of a growth arrest specific (gas5) gene by differential display as a candidate gene for determining susceptibility to hyperthermia-induced exencephaly in mice. Dev Genet 21 : 212 222.
88. van der Lugt NMT, Domen J, Linders K et al. 1994 Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 8 : 757 769.
89. van der Vlag J, Otte AP 1999 Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet 23 : 474 478.
90. Vorhees CV 1987 Teratogenicity and developmental toxicity of valproic acid in rats. Teratology 35 : 195 202.
91. Wang J, Mager J, Schnedier E, Magnuson T 2002 The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. Mamm Genome 13 : 493 503.
92. Warkany J, Petering HG 1972 Congenital malformations of the central nervous system in rats produced by maternal zinc deficiency. Teratology 5 : 319 334.
93. Wilson DB 1974 Proliferation in the neural tube of the splotch (Sp) mutant mouse. J Comp Neurol 154 : 249 256.
94. Wilson DB, Center EM 1974 Neural cell cycle in the Looptail mutant of the mouse (Lp). J Embryol Exp Morphol 32 : 697 705.
95. Wlodarczyk BJ, Bennett GD, Calvin JA, Finnell RH 1996 Arsenic-induced neural tube defects in mice: Alterations in cell cycle and gene expression. Reprod Toxicol 10 : 447 454.
96. Yu BD, Hess JL, Horning SE, Brown GAJ, Korsmeyer SJ 1995 Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378 : 505 508.